Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	595.88	204.92	-29.45
Graham Fair Price	-89.11	0.74	6.78
PEG	792827.29	1.02	< 0.005
Price/Book	-21.25	1.09	1.38
Price/Cash Flow	-99.70	-41.57	13800.05
Prices/Earnings	-6405.78	-100.31	-1.54
Price/Sales	-16.02	6.12	7.29
Price/FCF	-99.70	-41.57	13800.05
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.72	0.26	0.32
Operating Margin	98.90	-0.01	-1.23
ROA	98.77	< 0.005	-0.10
ROE	-0.22	< 0.005	98.79
ROIC	-0.14	< 0.005	98.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	0.12	-59.25
Dividends QOQ	0.69	5.88	757.79
EBIT QOQ	-264.37	0.99	-99.63
EPS QOQ	-120.43	0.99	-99.18
FCF QOQ	1.01	-261.71	25876.29
Revenue QOQ	-0.10	-0.06	34.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	107.97	101.09	-6.37
Days Sales Outstanding (DSO)	249.99	514.68	105.88
Inventory Turnover	0.83	0.89	6.81
Debt/Capitalization	0.39	0.38	-2.98
Quick Ratio	1.11	1.11	0.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.02	2.99	-1.04
Cash	2.18	0.64	-70.52
Capex	-0.07	-0.05	34.22
Free Cash Flow	< 0.005	-0.08	25770.31
Revenue	0.57	0.53	-7.20
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.26	1.25	-0.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.19	55.05	4520.32
Naive Interpretation	Member

06 - Financial Health · Weak

Rating